Silex Systems (SLX) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Feb, 2026Commercialisation strategy and technology highlights
SILEX laser enrichment technology offers higher efficiency and throughput than centrifuge methods, aiming for lower costs and classified under strict government security in Australia and the US.
GLE, a US-based JV (51% Silex, 49% Cameco), holds exclusive rights to commercialise SILEX technology, with Silex earning perpetual royalties of 7–12% on enrichment revenues.
Key technology demonstration (TRL-6) was completed in October 2025, de-risking the path to commercialisation and enabling progress to full-scale plant design.
GLE secured a 700-acre site in Paducah, KY, adjacent to DOE's former plant, with exclusive access to 150 million pounds of uranium tails for up to 30 years of feedstock.
US DOE awarded GLE up to $28.5m in January 2026 to advance next-generation enrichment technology.
Market opportunity and industry context
The US nuclear industry is experiencing a renaissance, with 94 reactors and strong public and private support, but remains heavily reliant on imported uranium and enrichment services.
Recent legislation, including the Prohibiting Russian Uranium Imports Act (2024), is driving demand for domestic supply solutions, with Russian imports banned from 2028.
Global nuclear fuel markets have tightened, with uranium, conversion, and enrichment prices rising 100–200% since 2022 due to geopolitical tensions and supply chain disruptions.
Forecasts show uncovered US uranium demand exceeding 25 million lbs annually from 2030, and enrichment demand rising to 14 million SWU by 2035.
GLE’s PLEF project is positioned as a single-site solution for US uranium, conversion, and enrichment, addressing critical supply chain vulnerabilities.
Financial and operational outlook
PLEF aims to produce up to 5 million lbs of natural uranium and 2 million kg of conversion capacity per year, with potential annual revenues of $450m (uranium) and $110m (conversion) at current prices.
Initial LEU production could reach 2 million SWU/year, expandable to 6 million SWU/year, with potential revenue of $350m/year at current SWU prices.
Silex’s equity in GLE and perpetual royalty structure provide dual value streams, with Cameco holding an option to increase its stake by 26% before April 2028.
As of December 2025, Silex held $200m in cash and term deposits, with no corporate debt.
Latest events from Silex Systems
- Cameco offtake and TRL-6 completion advance GLE toward targeted 2030 operations.SLX
AGM 2026 - DOE tails could underpin 5m lb/year uranium output, with first production targeted before end-2030.SLX
Mining Forum Americas 2026 - Revenue up, net loss down, TRL-6 milestone achieved, and strong cash reserves maintained.SLX
H2 2026 - SILEX laser enrichment advances toward US commercialisation, targeting major nuclear fuel market gaps.SLX
Investor presentation - Advancing laser enrichment and quantum silicon projects, with strong US support and no debt.SLX
Investor Presentation - Net loss widened to $42.6m as SILEX commercialisation advanced and cash reserves remained strong.SLX
H2 2025 - Revenue doubled and cash surged after a capital raise; GLE secured a major U.S. DOE award.SLX
H1 2026 - Financial strength and major technology milestones drive strategic U.S. nuclear market growth.SLX
AGM 2025 - Nuclear and quantum projects advanced, with strong cash reserves and key risks addressed.SLX
AGM 2024